Earnings Feed
Start Free
Home/Filings/4/0001209191-15-061869
4//SEC Filing

CHIASMA, INC 4

Accession 0001209191-15-061869

CIK 0001339469operating
View on SEC.govCompany Profile

Filed

Jul 20, 8:00 PM ET

Accepted

Jul 21, 4:32 PM ET

Size

36.1 KB

Accession

0001209191-15-061869

Insider Transaction Report

Form 4
Period: 2015-07-21
CHIASMA, INCCHMA
MPM BioVentures IV LLC
10% Owner
Transactions
  • Conversion

    Series E Preferred Stock

    2015-07-21−13,000,000→ 0 total(indirect: See Footnote)
    → Common Stock (1,423,566 underlying)
  • Conversion

    Series B-1' Preferred Stock

    2015-07-21−95,225→ 0 total(indirect: See Footnote)
    → Common Stock (10,426 underlying)
  • Conversion

    Series C' Preferred Stock

    2015-07-21−22,721,988→ 0 total(indirect: See Footnote)
    → Common Stock (2,488,171 underlying)
  • Conversion

    Common Stock

    2015-07-21+1,759,381→ 4,257,978 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2015-07-21+1,423,566→ 5,681,544 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2015-07-21+2,488,171→ 2,498,597 total(indirect: See Footnote)
  • Conversion

    Series D' Preferred Stock

    2015-07-21−16,066,669→ 0 total(indirect: See Footnote)
    → Common Stock (1,759,381 underlying)
  • Conversion

    Common Stock

    2015-07-21+10,426→ 10,426 total(indirect: See Footnote)
MPM BioVentures IV QP LP
10% Owner
Transactions
  • Conversion

    Common Stock

    2015-07-21+2,488,171→ 2,498,597 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2015-07-21+1,759,381→ 4,257,978 total(indirect: See Footnote)
  • Conversion

    Series B-1' Preferred Stock

    2015-07-21−95,225→ 0 total(indirect: See Footnote)
    → Common Stock (10,426 underlying)
  • Conversion

    Common Stock

    2015-07-21+10,426→ 10,426 total(indirect: See Footnote)
  • Conversion

    Series D' Preferred Stock

    2015-07-21−16,066,669→ 0 total(indirect: See Footnote)
    → Common Stock (1,759,381 underlying)
  • Conversion

    Common Stock

    2015-07-21+1,423,566→ 5,681,544 total(indirect: See Footnote)
  • Conversion

    Series C' Preferred Stock

    2015-07-21−22,721,988→ 0 total(indirect: See Footnote)
    → Common Stock (2,488,171 underlying)
  • Conversion

    Series E Preferred Stock

    2015-07-21−13,000,000→ 0 total(indirect: See Footnote)
    → Common Stock (1,423,566 underlying)
Scopa James Paul
10% Owner
Transactions
  • Conversion

    Common Stock

    2015-07-21+2,488,171→ 2,498,597 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2015-07-21+1,423,566→ 5,681,544 total(indirect: See Footnote)
  • Conversion

    Series B-1' Preferred Stock

    2015-07-21−95,225→ 0 total(indirect: See Footnote)
    → Common Stock (10,426 underlying)
  • Conversion

    Common Stock

    2015-07-21+1,759,381→ 4,257,978 total(indirect: See Footnote)
  • Conversion

    Series C' Preferred Stock

    2015-07-21−22,721,988→ 0 total(indirect: See Footnote)
    → Common Stock (2,488,171 underlying)
  • Conversion

    Series E Preferred Stock

    2015-07-21−13,000,000→ 0 total(indirect: See Footnote)
    → Common Stock (1,423,566 underlying)
  • Conversion

    Common Stock

    2015-07-21+10,426→ 10,426 total(indirect: See Footnote)
  • Conversion

    Series D' Preferred Stock

    2015-07-21−16,066,669→ 0 total(indirect: See Footnote)
    → Common Stock (1,759,381 underlying)
KAILIAN VAUGHN M
10% Owner
Transactions
  • Conversion

    Common Stock

    2015-07-21+10,426→ 10,426 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2015-07-21+1,759,381→ 4,257,978 total(indirect: See Footnote)
  • Conversion

    Series C' Preferred Stock

    2015-07-21−22,721,988→ 0 total(indirect: See Footnote)
    → Common Stock (2,488,171 underlying)
  • Conversion

    Series D' Preferred Stock

    2015-07-21−16,066,669→ 0 total(indirect: See Footnote)
    → Common Stock (1,759,381 underlying)
  • Conversion

    Series E Preferred Stock

    2015-07-21−13,000,000→ 0 total(indirect: See Footnote)
    → Common Stock (1,423,566 underlying)
  • Conversion

    Common Stock

    2015-07-21+2,488,171→ 2,498,597 total(indirect: See Footnote)
  • Conversion

    Series B-1' Preferred Stock

    2015-07-21−95,225→ 0 total(indirect: See Footnote)
    → Common Stock (10,426 underlying)
  • Conversion

    Common Stock

    2015-07-21+1,423,566→ 5,681,544 total(indirect: See Footnote)
MPM Asset Management Investors BV4 LLC
10% Owner
Transactions
  • Conversion

    Series D' Preferred Stock

    2015-07-21−16,066,669→ 0 total(indirect: See Footnote)
    → Common Stock (1,759,381 underlying)
  • Conversion

    Series C' Preferred Stock

    2015-07-21−22,721,988→ 0 total(indirect: See Footnote)
    → Common Stock (2,488,171 underlying)
  • Conversion

    Series E Preferred Stock

    2015-07-21−13,000,000→ 0 total(indirect: See Footnote)
    → Common Stock (1,423,566 underlying)
  • Conversion

    Common Stock

    2015-07-21+1,759,381→ 4,257,978 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2015-07-21+2,488,171→ 2,498,597 total(indirect: See Footnote)
  • Conversion

    Series B-1' Preferred Stock

    2015-07-21−95,225→ 0 total(indirect: See Footnote)
    → Common Stock (10,426 underlying)
  • Conversion

    Common Stock

    2015-07-21+10,426→ 10,426 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2015-07-21+1,423,566→ 5,681,544 total(indirect: See Footnote)
MPM BioVentures IV GmbH & Co. Beteiligungs KG
10% Owner
Transactions
  • Conversion

    Series D' Preferred Stock

    2015-07-21−16,066,669→ 0 total(indirect: See Footnote)
    → Common Stock (1,759,381 underlying)
  • Conversion

    Series C' Preferred Stock

    2015-07-21−22,721,988→ 0 total(indirect: See Footnote)
    → Common Stock (2,488,171 underlying)
  • Conversion

    Series E Preferred Stock

    2015-07-21−13,000,000→ 0 total(indirect: See Footnote)
    → Common Stock (1,423,566 underlying)
  • Conversion

    Common Stock

    2015-07-21+2,488,171→ 2,498,597 total(indirect: See Footnote)
  • Conversion

    Series B-1' Preferred Stock

    2015-07-21−95,225→ 0 total(indirect: See Footnote)
    → Common Stock (10,426 underlying)
  • Conversion

    Common Stock

    2015-07-21+1,423,566→ 5,681,544 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2015-07-21+10,426→ 10,426 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2015-07-21+1,759,381→ 4,257,978 total(indirect: See Footnote)
MPM BioVentures IV GP LLC
10% Owner
Transactions
  • Conversion

    Common Stock

    2015-07-21+2,488,171→ 2,498,597 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2015-07-21+1,423,566→ 5,681,544 total(indirect: See Footnote)
  • Conversion

    Series B-1' Preferred Stock

    2015-07-21−95,225→ 0 total(indirect: See Footnote)
    → Common Stock (10,426 underlying)
  • Conversion

    Common Stock

    2015-07-21+10,426→ 10,426 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2015-07-21+1,759,381→ 4,257,978 total(indirect: See Footnote)
  • Conversion

    Series C' Preferred Stock

    2015-07-21−22,721,988→ 0 total(indirect: See Footnote)
    → Common Stock (2,488,171 underlying)
  • Conversion

    Series E Preferred Stock

    2015-07-21−13,000,000→ 0 total(indirect: See Footnote)
    → Common Stock (1,423,566 underlying)
  • Conversion

    Series D' Preferred Stock

    2015-07-21−16,066,669→ 0 total(indirect: See Footnote)
    → Common Stock (1,759,381 underlying)
EVNIN LUKE
10% Owner
Transactions
  • Conversion

    Common Stock

    2015-07-21+1,423,566→ 5,681,544 total(indirect: See Footnote)
  • Conversion

    Series C' Preferred Stock

    2015-07-21−22,721,988→ 0 total(indirect: See Footnote)
    → Common Stock (2,488,171 underlying)
  • Conversion

    Series E Preferred Stock

    2015-07-21−13,000,000→ 0 total(indirect: See Footnote)
    → Common Stock (1,423,566 underlying)
  • Conversion

    Common Stock

    2015-07-21+10,426→ 10,426 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2015-07-21+2,488,171→ 2,498,597 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2015-07-21+1,759,381→ 4,257,978 total(indirect: See Footnote)
  • Conversion

    Series B-1' Preferred Stock

    2015-07-21−95,225→ 0 total(indirect: See Footnote)
    → Common Stock (10,426 underlying)
  • Conversion

    Series D' Preferred Stock

    2015-07-21−16,066,669→ 0 total(indirect: See Footnote)
    → Common Stock (1,759,381 underlying)
MPM Bio IV NVS Strategic Fund LP
10% Owner
Transactions
  • Conversion

    Common Stock

    2015-07-21+1,759,381→ 4,257,978 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2015-07-21+1,423,566→ 5,681,544 total(indirect: See Footnote)
  • Conversion

    Series B-1' Preferred Stock

    2015-07-21−95,225→ 0 total(indirect: See Footnote)
    → Common Stock (10,426 underlying)
  • Conversion

    Series E Preferred Stock

    2015-07-21−13,000,000→ 0 total(indirect: See Footnote)
    → Common Stock (1,423,566 underlying)
  • Conversion

    Common Stock

    2015-07-21+10,426→ 10,426 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2015-07-21+2,488,171→ 2,498,597 total(indirect: See Footnote)
  • Conversion

    Series C' Preferred Stock

    2015-07-21−22,721,988→ 0 total(indirect: See Footnote)
    → Common Stock (2,488,171 underlying)
  • Conversion

    Series D' Preferred Stock

    2015-07-21−16,066,669→ 0 total(indirect: See Footnote)
    → Common Stock (1,759,381 underlying)
Footnotes (9)
  • [F1]The shares, on a common stock equivalent basis, were converted as follows: 9,773 by MPM BioVentures IV-QP, L.P. ("BV IV QP"), 376 by MPM BioVentures IV GmbH & Co. Beteiligungs KG ("BV IV KG") and 277 by MPM Asset Management Investors BV4 LLC ("AM BV4"). MPM BioVentures IV GP LLC ("BV GP LLC") and MPM BioVentures IV LLC ("BV LLC") are the direct and indirect general partners of BV IV QP and BV IV KG and BV LLC is the manager of AM BV4. Ansbert Gadicke, Luke Evnin, Vaughn M. Kailian, James Paul Scopa and Todd Foley are the members of BV LLC. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
  • [F2]The shares of Series B-1' Preferred Stock, Series C' Preferred Stock, Series D' Preferred Stock and Series E Preferred Stock converted into 0.109505 of a share of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares had no expiration date.
  • [F3]The shares are held as follows: 9,773 by BV IV QP, 376 by BV IV KG and 277 by AM BV4. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
  • [F4]The shares, on a common stock equivalent basis, were converted as follows: 1,479,910 by BV IV QP, 57,016 by BV IV KG, 42,083 by AM BV4 and 909,162 by MPM Bio IV NVS Strategic Fund, L.P. ("BV IV SF"). BV GP LLC and BV LLC are the direct and indirect general partners of BV IV SF. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
  • [F5]The shares are held as follows: 1,489,683 by BV IV QP, 57,392 by BV IV KG, 42,360 by AM BV4 and 909,162 by BV IV SF. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
  • [F6]The shares, on a common stock equivalent basis, were converted as follows: 1,539,486 by BV IV QP, 59,313 by BV IV KG, 43,776 by AM BV4 and 116,806 by BV IV SF. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
  • [F7]The shares are held as follows: 3,029,169 by BV IV QP, 116,705 by BV IV KG, 86,136 by AM BV4 and 1,025,968 by BV IV SF. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
  • [F8]The shares, on a common stock equivalent basis, were converted as follows: 939,089 by BV IV QP, 36,179 by BV IV KG, 26,704 by AM BV4 and 421,594 by BV IV SF. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
  • [F9]The shares are held as follows: 3,968,258 by BV IV QP, 152,884 by BV IV KG, 112,840 by AM BV4 and 1,447,562 by BV IV SF. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.

Documents

1 file

Issuer

CHIASMA, INC

CIK 0001339469

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001339469

Filing Metadata

Form type
4
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 4:32 PM ET
Size
36.1 KB
View on SEC.gov